QUAL vs XBI
iShares MSCI USA Quality Factor ETF vs SPDR S&P Biotech ETF
- • QUAL has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • QUAL pays a higher dividend yield (0.85%).
Side-by-side metrics
| Metric | QUAL | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.85% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $48.05B | $10.92B |
YTD return | 13.54% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.87 | 1.01 |
P/E ratio | 26.52 | — |
Last price | $56.37 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
QUAL top holdings
| MSFT | Microsoft Corp | 7.97% |
| AAPL | Apple Inc | 7.35% |
| NVDA | NVIDIA Corp | 5.92% |
| LLY | Eli Lilly and Co | 4.48% |
| META | Meta Platforms Inc Class A | 4.04% |
| V | Visa Inc Class A | 3.55% |
| TJX | TJX Companies Inc | 3.52% |
| LRCX | Lam Research Corp | 2.83% |
| XOM | ExxonMobil Holdings Corp | 2.61% |
| MA | Mastercard Inc Class A | 2.52% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About QUAL
QUAL (iShares MSCI USA Quality Factor ETF) is US large-caps screened for quality factors. Managed by iShares, the fund carries $48.0B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.85%. Its largest holding is Microsoft Corp (MSFT), which represents 8.0% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.